Vaccinex files prospectus supplement for up to $4.39M ATM offering via Jefferies

VACCINEX, INC.

May offer and sell up to $4,391,000 of common stock from time to time.
Sales agent Jefferies LLC under existing Open Market Sale Agreement dated March 27, 2020.
Proceeds used for general corporate purposes and clinical development.
Hogan Lovells opinion on validity of shares attached as exhibit.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.